Meglumine antimoniate how supplied

Revision as of 03:43, 7 January 2014 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Meglumine Antimoniate
GLUCANTIM® WHO Prescribing Information
Description
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied

Injection containing the equivalent of 85 mg/ml (meglumine antimoniate) or 100 mg/ml (sodium stibogluconate) of antimony (Sb5+), in 5-ml ampoule.

Storage

Ampoules should be stored in well-closed containers, protected from light. It should be noted that antimonial compounds are polymers that may deteriorate with age.[1]

References

  1. "WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Leishmaniasis: Meglumine antimoniate and sodium stibogluconate".

Adapted from the FDA Package Insert.